Ayu. Dec/31/2014; 36(1): 101-106

PMID: 26730148

PMC: 4687229

Protective effect of Agave americana Linn. leaf extract in acetic acid-induced ulcerative colitis in rats

Basheerahmed A.A. Mannasaheb

Preeti V. Kulkarni

Mashood Ahmed Sangreskopp

Chetan Savant

Anjana Mohan

Abstract

Introduction:

Natural plants always provide core compounds for new drug development. In the present life and food style, inflammatory bowel disease has become common and needs a lead compound for its drug development.

Aim:

To evaluate the effect of Agave americana Linn. leaf extract in acetic acid-induced ulcerative colitis in rats based on its traditional anti-inflammatory use.

Materials and Methods:

Male Wistar rats were pretreated with A. americana leaf extract in the dose of 200 and 400 mg/kg p.o. daily for 7 days. On 8^th day, 2 ml of 4% v/v acetic acid in saline was instilled into rats’ rectum. Prednisolone was used as standard drug and it was administered on the day of acetic acid instillation and continued for 3 days. Extract treatment was continued till 11^th day. Body weight, ulcer score, colonic muscle contraction, antioxidant activity and histopathology were studied. Statistical analysis was performed using Parametric one-way analysis of variance followed by Tukey's posttest.

Results:

A. americana have retained total body weight significantly (P < 0.01) and decreased colon weight/length ratio. Extract have shown a significant decrease (P < 0.001) in ulcer scores, myeloperoxidase, lipid peroxidase activity. Further, extract have shown significant improvement in colonic muscle contraction, histopathology of colon etc., which is comparable with standard drug.

Conclusion:

A. americana possess protective effect against acetic acid-induced colitis in rats.

Introduction

Ulcerative colitis is a major form of inflammatory bowel disease (IBD). Ulcerative colitis and Crohn's disease together constitute IBD. Crohn's disease may be localized in any part of the digestive tract and affects the entire intestinal wall whereas ulcerative colitis is confined to the colon and rectum, and the inflammation is restrained to the intestinal lining.[1] IBD is a growing worldwide health burden. Specifically, many developing countries have seen a dramatic rise in the incidence of IBD since 1990.[2] Although etiology of IBD is unknown it appears that an abnormal response of the mucosal innate immune system to luminal bacteria may trigger inflammation that is perpetual by deregulation of cellular immunity.[3 4 5] Free radicals contribute, aggravate and precipitate pathological changes in the colonic mucosa and have been proposed as therapeutic targets. Localized inflammation, neutrophil infiltration and vicious cascade of generation of inflammatory mediators have been elucidated to damage the colonic mucosal.[6]

IBD, an incurable disease, places a heavy burden on populations because it reduces the quality of life and capacity for work and increases disability. The prevalence of IBD is >200 cases/100,000 inhabitants in the West and IBD has a major impact on health care resources.[7] The most common classes of medications used in the treatment of IBD include the 5-aminosalicylates (agents), corticosteroids, immunosuppressive agents, antibiotics, and biological agents.[8]

Phyto-botanical and ethno-botanical researches have focused for decades on the search for the single “active principle” in plants, based on the assumption that a plant has one or few ingredients that determine therapeutic effects. But the traditional system of medicine like Ayurveda, traditional Chinese medicine or the European pharmacotherapy generally assumes that a synergy of all ingredients of the plants will bring about the maximum therapeutic efficacy.[9] Reports suggests that 80% drug molecules are natural products or natural compound inspired.[10] The leaves of Agave americana Linn. (Family: Agavaceae) are used as demulcent, hepatoprotective, antioxidant, antiseptic and to relieve various liver diseases.[11] The sap of the leaves has anti-inflammatory activity and is used internally in case of wounds and inflammation.[12]

The major phyto constituents present in A. americana are saponins, that are a vast group of glycosides, widely distributed in higher plants. Pharmacological properties of saponins include anti-inflammatory, antifungal, antibacterial, antiparasitic, and antitumor activity.[13] Hence, the above plant is used to study its effect as anti-inflammatory in acetic acid-induced ulcerative colitis.

To the best of our knowledge, no scientific data regarding the activity of A. americana on IBD is available in the literature. Therefore, this work has been undertaken.

Materials and Methods

Drugs and chemicals

Prednisolone, acetic acid, tween 60, sodium carboxymethylcellulose, O-dianisidine hydrochloride, hexadecyl trimethyl ammonium bromide, and trichloro acetic acid was purchased from Hi Media, Mumbai, Maharashtra, India. All chemicals used were of analytical grades.

Plant material and preparation of extract

Fresh leaves of A. americana were collected from surrounding areas of Dharwad, Karnataka and authenticated at Department of Botany. The plant material was washed with running water. Fresh leaves of the plant pounded well by using mortar and pestle. The obtained herbal juice was filtered, and the filtrate was subjected to rotary flash evaporator under reduced pressure to dryness. The dried extract was stored in desiccators till use.[14]

Preliminary phytochemical investigation

The A. americana leaf extract was subjected to preliminary phytochemical investigation as per standard procedure.[15]

Animals

Male Wistar rats (since female rats show physiological and hormonal changes that may affect results) weighing 150–200 g were used for the present study. For acute toxicity study, female albino mice were used. The animals were procured and maintained in the animal house for experimental purpose. The animals were maintained under controlled conditions of temperature (22 ± 2°C), humidity (50 ± 5%) and 12-h light-dark cycles. They were fed with commercial stock diet and water, ad libitum. The animals were housed individually in sanitized polypropylene cages containing sterile paddy husk as bedding. Animals were habituated to laboratory conditions for 48 h prior to the experimental protocol to minimize nonspecific stress if any. All the studies conducted were approved by the Institutional Animal Ethics Committee (REG. No. 112/1999/CPCSEA) according to prescribed guidelines of CPCSEA, Government of India.

Experimental method

Determination of acute toxicity

Acute toxicity study was carried out using female albino mice (20–30 g) by up and down/staircase method using OECD 423 guidelines. The A. americana leaf extract was orally administered to mice at the doses of 50, 300, 1000, 2000 and 4000 mg/kg body weight respectively. Animals were observed for 48 h to study the general behavior of animals, signs of discomfort and the nervous manifestation. The A. americana leaf extract was found devoid of mortality of animals at the dose of 4000 mg/kg body weight. Hence, the 1/10^th (400 mg/kg, p.o.) and 1/20^th (200 mg/kg, p.o.) of the doses were selected.

Acetic acid-induced colitis in rats

The animals were divided into five groups, each containing 6 rats:

Group 1: Normal control (treated with vehicle)
Group 2: Positive control (acetic acid 2 ml of 4% intra-rectally)
Group 3: A. americana extract (200 mg/kg) + acetic acid
Group 4: A. americana extract (400 mg/kg) + acetic acid
Group 5: Prednisolone (2 mg/kg)[16] + acetic acid.

Agave americana extracts were administered for 7 consecutive days. On the 8^th day, overnight fasted animals were anaesthetized using pentobarbitone sodium and 2 ml of acetic acid (4% v/v in 0.9% saline) was instilled into the rectum. Animals were allowed to hang in air by holding their tails for 1–2 min. This prevents spillage of solution from rectum. Extract and standard drug treatment were continued till 11^th day. On 11^th day, animals were weighed and sacrificed and dissected to remove colon. Inflammation was assessed based on physical parameters, macroscopy and microscopic features. Quantification of inflammation was done using biochemical assay.[16 17]

Physical parameters assessed

Change in:

Body weight
Colon weight
Colon length
Colon weight/length ratio.

As the weight loss is one of the clinical symptoms, all the rats from respective groups were weighed each day, and the percentage of the original weight is used for evaluation.[18 19 20]

Ulcer scoring for colon

For each animal, the distal 10 cm portion of the colon was removed and cut longitudinally, and slightly cleaned in physiological saline to remove fecal residues. Pieces of colon (10 cm long each) were scored for macroscopic features using scoring pattern.[16]

Antioxidant activity

Myeloperoxidase and lipid peroxidase assay

The colitis caused by acetic acid was associated with an increase in myeloperoxidase (MPO) and lipid peroxidase (LPO) activity.[16 18]

Colonic muscle contraction activity

Tissue preparation

After a laparotomy incision, a portion of the colon was removed and placed in an oxygenated Tyrode's solution. A segment of 2 cm length colon were mounted in a 10 ml organ bath containing Tyrode's solution that was bubbled with a 95% O₂ and 5% CO₂ mixture and the temperature was held at 37°C.

Measurement of smooth muscle contractility

Each segment was allowed to equilibrate in the bath for 30 min. Muscle contraction was measured using 10 µg solution of acetylcholine in student's organ bath apparatus. Different responses were recorded on kymograph and percentage response was calculated for each group.[21]

Evaluation based on microscopic (histological) characters

The colon from each animal was removed after sacrificing the animal and collected and preserved in 10% formalin solution. The samples were studied for histological changes.

Statistical analysis

All data was expressed as mean ± standard error of the mean of 6 rats per experimental group. Statistical analysis was performed using the GraphPad Prism 5.0 (GraphPad Software, Inc. La Jolla, USA) statistical software. Parametric one-way analysis of variance is followed by Tukey's posttest. The minimal level of significance was identified at P < 0.05.

Results

The phytochemical investigation of A. americana leaf extract showed the presence of steroids, triterpenoids, saponin glycosides, flavonoids, alkaloids and carbohydrates.

Evaluation based on body weight shows that there was significant (P < 0.001) decrease in the body weight of induced group compared with the normal group [Figure 1]. The animals treated with 200 mg/kg, 400 mg/kg leaf extract and the standard group could retain their total body weight compared with the positive control group [Table 1]. The acetic acid induction significantly (P < 0.001) increased the colon weight of positive control group compared to the normal group. Whereas the animals treated with 200 mg/kg, 400 mg/kg extract (P < 0.01) and standard group (P < 0.001) decreased the colon weight significantly compared with positive control group [Table 2]. The disease induction by instillation of acetic acid intra-rectally causes significant (P < 0.001) shrinkage in the colon length of the positive control group compared to normal control. The animals treated with 200 mg/kg, 400 mg/kg extract (P < 0.01) and standard group increased the colon length significantly (P < 0.001) compared with positive control group [Table 2].

Figure 1

Effect of Agave americana leaf extract on body weight in acetic acid-induced colitis

Table 1

Effect of Agave americana leaf extract on body weight in acetic acid-induced colitis

Table 2

Effect of Agave americana leaf extract on colon weight (g), length (cm) and weight/length ratio (mg/cm) in acetic acid-induced colitis

The colon weight/length (mg/cm) ratios was significantly (P < 0.001) increased in positive control group compared to normal control group. Whereas the animals treated with 200 mg/kg, 400 mg/kg extract and standard group significantly reduced (P < 0.001) the colon weight/length ratio [Table 2].

Intra-rectal instillation of acetic acid caused an inflammatory reaction in the colon. The inflammation covered rectum and distal colon portion. The visible changes include severe epithelial necrosis and ulcerated mucosa. Evaluation based on macroscopic features showed score values significantly increased (P < 0.001) in the positive control as compared with normal control group. The treatment with plant extract 200 mg/kg, 400 mg/kg and standard drug showed significantly (P < 0.001) decreased score values as compared to the positive control group. The values obtained for the drug-treated group (especially 400 mg/kg) was comparable with that of standard treated group [Table 3].

Table 3

Effect of Agave americana leaf extract on ulcer score, MPO activity and LPO assay in acetic acid-induced colitis

The colitis caused by acetic acid was associated with an increase in MPO activity. The MPO assay showed significant (P < 0.001) increase in MPO activity of positive control (group compared to normal control group). The animals treated with extract and standard group showed significant (P < 0.001) decrease in MPO activity compared to the positive control group [Table 3]. The LPO assay showed significant (P < 0.001) increase in LPO activity of positive control group compared to normal control group. The animals treated with plant extract, and standard group showed significant (P < 0.001) decrease in LPO activity compared to the positive control group [Table 3]. The colonic muscle contractions were recorded using acetylcholine and Tyrode solution showed a significant decrease in percentage response compared to normal control group, which indicates severe damage to colonic tissue and receptors [Table 4]. On the other hand, there was a significant increase in percentage response in standard and drug-treated groups compared to the positive control [Figure 2].

Table 4

Effect of Agave americana leaf extract on colonic muscle contractility using acetylcholine (10 μg) and Tyrode's solution in acetic acid-induced colitis

Figure 2

Effect of Agave americana leaf extract on colonic muscle contractility using acetylcholine (10 μg) and Tyrode solution in acetic acid-induced colitis

Histological examination of positive control group showed massive necrosis of the mucosa and sub mucosa. Test groups (200 and 400 mg/kg body weight) showed mild lesions, regeneration and inflammatory reaction. The standard group showed suppressed inflammatory reaction [Figure 3a–e].

Figure 3

Histopathological examination of colon (colonic mucosal sections): (a) Normal rat showing normal mucosa with intact epithelial surface, (b) Acetic acid-induced colitis showing massive necrotic destruction of epithelium, (c-d) Treatment with extract of Agave americana leaf 200 mg/kg and 400 mg/kg showing decreased epithelial damage, regeneration and suppressed inflammatory reaction, (e) Standard group showed suppressed inflammatory reaction

Discussion

Ulcerative colitis is a refractory, chronic, and nonspecific disease occurring usually in the rectum and the entire colon. The primary aims of medical therapy for patients with ulcerative colitis are directed at inducing and then maintaining remission of symptoms and mucosal inflammation to provide an improved quality of life with the least amount of steroid exposure.[22] According to traditional claims, A. americana leaf exhibits anti-inflammatory, wound healing and antioxidant property.[11 23]

Decrease in body weight is one of the symptoms of ulcerative colitis. The present studies have shown a significant decrease in body weight of positive control group compared to normal control group. There was a significant increase in body weight in extract treated groups showing its protective effect in ulcerative colitis.

Other findings with IBD are abnormal histopathological features and increased intestinal permeability. Results have also shown the shrinkage of colon and increase in colon weight in positive control group, which indicates severe inflammation along with increased intestinal permeability. A. americana extract treated animals have shown a significant decrease in shrinkage and weight of the colon indicating its anti-inflammatory effect.

Mediators like tumor necrosis factor-alpha, interleukin-6 (IL₆), and LB₄ plays an important role in the inflammation of the intestinal mucosa in animal models of IBD. Results have shown a significant decrease in ulcer score of extract treated animals compared to positive control group proving its beneficial effect in ulcerative colitis. In IBD, the inflammatory process is probably derived from the chronic presence of numerous, activated MPO-containing phagocytes in the inflamed intestine. MPO assay has provided data supporting protective effect of the extract showing significant decrease in MPO activity in the extract treated groups compared to the positive control.

Oxidative stress also plays an important role in the pathophysiology of IBD.[24] In patients with IBD, especially ulcerative colitis, the repeated cycle of injury of the intestinal mucosa has been shown to increase the risk of colon cancer.[25] LPO assay is an indicator of oxidative stress and reactive metabolites. Results have shown there was a significant increase in LPO activity in acetic acid-induced group whereas significant decrease in LPO activity has been observed in the extract and standard drug-treated groups.

Dose response curve of acetylcholine (Ach) using isolated rat colon from each different group has been carried, which has provided data supporting beneficial effect of A. americana in ulcerative colitis. There was a significant decrease in % response in an induced group indicating severe necrosis, damage and ulcer in the colon that leads to decrease in a number of muscarinic receptors hence reduced % response by Ach. On the other hand, extract and standard drug-treated groups have shown a significant increase in % response indicating healing and protective effect in acetic acid-induced ulcerative colitis.

Histopathological studies have shown severe necrosis and edema in induced group. Whereas extract treated groups have shown intact intestinal mucosa along with regeneration of intestinal epithelium cells providing protective mechanism.

In all above studied parameters, extract treated groups have shown better results that are comparable with the standard prednisolone treated group. And the possible mechanism of action may be by decreasing the number of neutrophils and reduction in the synthesis of inflammatory mediators and by increasing protective and regenerative property.

Conclusion

Agave americana leaf extract has significant protective effect against acetic acid-induced colitis models. This investigation has opened avenues for the treatment of IBD from the A. americana.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

References

1. Krzystek-KorpackaMNeubauerKMatusiewiczMPlatelet-derived growth factor-BB reflects clinical, inflammatory and angiogenic disease activity and oxidative stress in inflammatory bowel diseaseClin Biochem20094216029[PubMed][Google Scholar]
2. LutherJDaveMHigginsPDKaoJYAssociation between Helicobacter pylori infection and inflammatory bowel disease: A meta-analysis and systematic review of the literatureInflamm Bowel Dis201016107784[PubMed][Google Scholar]
3. GhoshPKandhareADGaubaDRaygudeKSBodhankarSLDetermination of efficacy, adverse drug reactions and cost effectiveness of three triple drug regimens for the treatment of H. pylori infected acid peptic disease patientsAsian Pac J Trop Biomed20122S783S9[Google Scholar]
4. GhoshPKandhareADRaygudeKSGaubaDGosaviTPBodhankarSLCigarette smoking and H. pylori infection: A meta-analysis of literaturePharm Lett2012412834[Google Scholar]
5. RaygudeKSKandhareADGhoshPGosaviTPBodhankarSLConsumption of alcohol and H. pylori infection: A cumulative meta-analysis of literatureAsian J Biochem Pharm Res2011333845[Google Scholar]
6. StroberWFussIJProinflammatory cytokines in the pathogenesis of inflammatory bowel diseasesGastroenterology2011140175667[PubMed][Google Scholar]
7. CosnesJGower-RousseauCSeksikPCortotAEpidemiology and natural history of inflammatory bowel diseasesGastroenterology2011140178594[PubMed][Google Scholar]
8. VarshosazJEmamiJAhmadiFTavakoliNMinaiyanMFassihiAPreparation of budesonide-dextran conjugates using glutarate spacer as a colon-targeted drug delivery system: In vitro/in vivo evaluation in induced ulcerative colitisJ Drug Target20111914053[PubMed][Google Scholar]
9. Ulrich-MerzenichGPanekDZeitlerHVetterHWagnerHDrug development from natural products: Exploiting synergistic effectsIndian J Exp Biol20104820819[PubMed][Google Scholar]
10. BhutaniKKGohilVMNatural products drug discovery research in India: Status and appraisalIndian J Exp Biol201048199207[PubMed][Google Scholar]
11. ShanthasheelaRChithraMVijayachitraREvaluation of hepatoprotective activity of combination of Anethum graveolens and Agave americana on CCl4 intoxicated ratsIndian Drugs2007449502[Google Scholar]
12. PeanaATMorettiMDManconiVDesoleGPippiaPAnti-inflammatory activity of aqueous extracts and steroidal sapogenins of Agave americanaPlanta Med199763199202[PubMed][Google Scholar]
13. SpargSGLightMEvan StadenJBiological activities and distribution of plant saponinsJ Ethnopharmacol20049421943[PubMed][Google Scholar]
14. VijayachitraRChitraMShanthasheelaREfficacy of leaf extract of Agave americana L.against CCl4 induced hepatic damage in albino ratsJ Sci Trans Environ Technol2008213[Google Scholar]
15. KhandelwalKRPractical Pharmacognosy Techniques and Experiments20002nd edPuneNirali Prakashan269
16. HagarHHEl-MedanyAEl-EterEArafaMAmeliorative effect of pyrrolidinedithiocarbamate on acetic acid-induced colitis in ratsEur J Pharmacol20075546977[PubMed][Google Scholar]
17. JagtapAGShirkeSSPhadkeASEffect of polyherbal formulation on experimental models of inflammatory bowel diseasesJ Ethnopharmacol200490195204[PubMed][Google Scholar]
18. JurjusARKhouryNNReimundJMAnimal models of inflammatory bowel diseaseJ Pharmacol Toxicol Methods2004508192[PubMed][Google Scholar]
19. HarisaGEAbo-SalemOMEl-Sayedel-SMTahaEIEl-HalawanyNL-arginine augments the antioxidant effect of garlic against acetic acid-induced ulcerative colitis in ratsPak J Pharm Sci20092237380[PubMed][Google Scholar]
20. PaivaLAGurgelLADe SousaETSilveiraERSilvaRMSantosFAProtective effect of Copaifera langsdorffii oleo-resin against acetic acid-induced colitis in ratsJ Ethnopharmacol200493516[PubMed][Google Scholar]
21. GilaniAHBashirSJanbazKHKhanAPharmacological basis for the use of Fumaria indica in constipation and diarrheaJ Ethnopharmacol2005965859[PubMed][Google Scholar]
22. KeFYadavPKJuLZHerbal medicine in the treatment of ulcerative colitisSaudi J Gastroenterol201218310[PubMed][Google Scholar]
23. BeheraJPMohantyBRamaniYRRathBPradhanSEffect of aqueous extract of Aegle marmelos unripe fruit on inflammatory bowel diseaseIndian J Pharmacol2012446148[PubMed][Google Scholar]
24. MehrabaniDBahramiFHosseiniSVAshrafMJTanidehNRezaianzadehAthe healing effect of Teucrium polium in acetic acid-induced ulcerative colitis in the dog as an animal modelMiddle East J Dig Dis20124407[PubMed][Google Scholar]
25. KurianJCPlants That Heal1995PuneOriental Watchman Publishing House278